Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XACENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XACENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.315ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.516ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.354ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.162ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.426ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.402ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.402ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.590ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.590ENiu-ECACGTTAACAATATTGCAGC20402639126372R-16283.8China
B.1.116ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.496ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.496ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.49 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.49 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.507ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.495ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.495ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.294ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.453ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used